Elsevier, a global leader in research publishing and information analytics and part of RELX has closed the acquisition of Interfolio, a provider of advanced faculty information solutions for higher education.
With this acquisition, Interfolio will be part of Elsevier’s Research Intelligence portfolio, which includes Scopus, SciVal, Pure and Digital Commons. The combined portfolio will deliver analysis and insights that help academic researchers, research leaders, institutions and funders achieve their strategic goals.
Founded in 1999, Interfolio is an education technology company that serves colleges and universities, funders and research organizations, and individual scholars. More than 400 clients based in 25 countries choose Interfolio’s solutions for hiring and recruitment, academic appointments and timelines, activity data reporting, faculty reviews and promotions, and research impact analysis.
Headquartered in Washington DC, US, Interfolio provides scholar-first products for the full academic lifecycle—from job seeking to professional accomplishments, committee service, funding award compliance, career growth and advancement, administrative leadership, and beyond.
Commenting on the acquisition, Chief Executive Officer of Interfolio, Andrew Rosen, said:
“I am incredibly proud of everyone at Interfolio. We have a singular focus: helping our customers to understand and effectively manage the huge amount of activity that scholars accomplish. As part of Elsevier, we will retain this focus and strengthen our core products for our customers. We will aim to support more institutions internationally, increase data automation to help our customers improve efficiency, and provide sophisticated analytics tools to expand insights and facilitate scholarly work. This is an exciting next step for our business, and I look forward to working with the Elsevier team.”
Based in the Netherlands, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. The company does this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
The company employs 8,700 people worldwide. It has supported the work of the research and health partners for more than 140 years. Growing from its roots in publishing, Elsevier offers knowledge and valuable analytics that helps its users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on its over 2,700 digitized journals, including The Lancet and Cell.
With the Elsevier Foundation and its external Inclusion & Diversity Advisory Board, the firm works in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Theo Pillay, General Manager of Research Institutional Products, Elsevier, added:
“Interfolio has an unparalleled understanding of scholarly faculty activity and managing research assessment data. Its solutions will strengthen our Research Intelligence portfolio and there are strong synergies that will help us deliver increased and accelerated value to both Elsevier and Interfolio customers and users. I am very pleased to welcome the Interfolio team to Elsevier.”
Post the acquisition, Macquarie Capital served as exclusive financial advisor to Interfolio.
Last year in December, Elsevier acquired Osmosis.org, a Salt Lake City-based digital health education platform.
